Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

✍ Scribed by Daniel C. Javitt; Robert W. Buchanan; Richard S.E. Keefe; Robert Kern; Robert P. McMahon; Michael F. Green; Jeffrey Lieberman; Donald C. Goff; John G. Csernansky; Joseph P. McEvoy; Fred Jarskog; Larry J. Seidman; James M. Gold; David Kimhy; Karen S. Nolan; Deanna S. Barch; M. Patricia Ball; James Robinson; Stephen R. Marder

• Book ID: 119366032
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 799 KB
• Volume: 136
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/j.schres.2011.11.001